Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Type 1 Diabetes Mellitus · Dehydration · HALO

HALOZYME THERAPEUTICS

HALOZYME THERAPEUTICS, INC.

HALOZYME THERAPEUTICS trial registry — 48 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
12390 El Camino Real, San Diego, California 92130, US HQ
2021 Founded
530 Employees
Public company Type
HALO · NYSE Ticker
Company details
Status
Public
HQ
12390 El Camino Real, San Diego, California 92130, US
Founded
2021
Employees
530
Programs
45
Drugs
33
Patents
70
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Trials

HALOZYME THERAPEUTICS clinical trials

Registry index of 48 ClinicalTrials.gov studies linked to HALOZYME THERAPEUTICS programs — each row shows trial ID, program name, phase, status, and indication.

HALOZYME THERAPEUTICS trial registry — 48 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for HALOZYME THERAPEUTICS.

  1. 1838-009 — Approved

    Clinical update

  2. Testosterone enanthate — Phase 3

    Clinical update

  3. Recombinant human hyaluronidase PH20 (rHuPH20) — Phase 1

    Clinical update

  4. recombinant human hyaluronidase — Approved

    Clinical update

  5. recombinant human hyaluronidase — Approved

    Clinical update

  6. Rapid Acting insulin with pre-treatment of rHuPH20 — Approved

    Clinical update

  7. PEGylated recombinant human hyaluronidase PH20 — Phase 1

    Clinical update

  8. Isotonic hydration fluid and recombinant human hyaluronidase — Approved

    Clinical update

Trial registry

48 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.